The Humanized Mice Model Market size was valued at USD 95.72 Million in 2022 and is projected to reach USD 188.57 Million by 2030, growing at a CAGR of 9.54% from 2022 to 2030.

Humanized Mice Model Market Overview:

Fruit purees have often been replaced by imitation products and low-standard fruit purees, some of which have been noticed and banned worldwide in recent years. Consumer anxiety about the origin of raw fruit has been a focus, and consumers are willing to pay much more to get genuine products.

Some manufacturers have responded to consumer demand by improving the traceability of their products by coding them and creating traceability to specific farms around the world. This has resulted in a wide range of applications for certain fruit pureed products, one of which is avocado puree.

Humanized Mice Model Market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Humanized Mice Model Market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Key Market Updates:

• In September 2021, genOway, a biotechnology company dedicated to the design and development of preclinical models, announced the acquisition of Axenis, a company dedicated to developing immunocompromised models for validation of new and innovative therapeutics.
• In January 2022, Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announced the release of the huNOG-EXL Early Access (EA) humanized immune system (HIS) mouse. This product expands Taconic's widely used HIS portfolio. The huNOG-EXL EA significantly extends the duration of studies in which myeloid lineage HIS mouse models can be successfully used.
• In October 2021, The Jackson Laboratory (JAX), a non-profit biomedical research organization based in the US, announced that it would acquire Charles River Laboratories Japan's Research Models & Services (RMS) business as a wholly owned subsidiary. The Japan-based organization, which will be named Jackson Laboratory Japan, has approximately 250 employees and three production facilities in Atsugi, Hino and Tsukuba and a management office in Yokohama.

Major Market Segments Covered in Humanized Mice Model Market Industry Research:

Market Key Players:
Ingenious Targeting Laboratory, Axen, rans Genic Inc., Horizon Discovery Group PLC, HuMurine Technologies, Champions Oncology Inc., And Others.

By Type:

• Humanized Mouse Models
• Humanized Rat Models

By Application:

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutions

By Region:
North America holds the majority share, accounting for 41.5% revenue of the global humanized mouse models market in 2022. This large share is due to increased R&D spending by pharmaceutical companies and increased biomedical research. Presence of prominent market players in the region and developments in the pharmaceutical and research sectors are likely to be the main drivers.

According to recent research publications, rat and mouse models cover 99.3% of mammals used in 16 large US organizations. Therefore, high consumption rates of these models in these regions fuel revenue growth. North America has witnessed tremendous technological advances that have led to the development of transgenic mice, knock-in mice, and knock-out mice.

Efforts to eliminate the limitations of orthodox xenograft models by inserting human hematopoietic stem cells into mouse bone marrow and inserting mouse liver into human hepatocytes have provided new growth prospects for the market.

Europe held the second largest market share with a share of 33.4% owing to the increase in research activities related to the use of rodent models. In September 2021, a research team from the Universitat Autonoma de Barcelona (UAB); Spain has generated a rat model that can recapitulate the disability changes observed in patients with Morquio A disease or Mucopolysaccharidosis type IVA.

Scientists have also successfully tested gene therapy to treat systemic changes observed in a mouse model of Morquio A disease. Research activities of this kind could potentially lead to the discovery of new therapies to treat young patients with life-threatening transformations. This also reassures drug developers to use rodent models for drug discovery and development.

Expansion of medical budgets and favorable government policies have stimulated the development of new drugs for cancer treatment. Rising healthcare expenditure and prevalence of chronic diseases have increased the demand for humanized mouse models in this region.

The humanized mouse models market is expected to witness high growth rates in the Asia-Pacific region, owing to increasing private sector and government investments in life sciences, regenerative medicine research, increasing animal research, and growing interest in personalized medicines. , growth in translational and biomedical research, growth in the pharmaceutical industry, and increased pharmaceutical and biotech R&D activity in the region.

Additionally, increasing number of contract research institutes in the region and more funding directed to R&D sector aligned with pharmaceutical and biopharmaceutical sectors have boosted the human mouse model market in Asia Pacific.

The region is expected to remain a rewarding regional humanized mouse model market in the coming years due to the growing influx of research activities by regional CMOs. The increasing application of humanized mouse models in immunology and epidemiological and oncology sectors serves as a prominent driver for the humanized mouse models market in these regions.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Drivers

The humanized mouse model market is poised to rise due to the increasing demand for personalized medicines designed using animal models, especially mouse models. Human tissues are transplanted into immunodeficiency models and disease manifestations are registered. Then, to find the most suitable treatment, the model is treated with various drugs or gene therapy to provide suitable or customized drugs to the patient, increasing the factors that will influence the global market. Also advances in genomics, proteomics and metabolomics; completion of the Human Genome Project; growth in personalized diagnostics and therapeutics; Growing interest in wellness, wellness and prevention is increasing the demand for personalized medicine.

Challenges

Despite numerous drivers, the high cost of humanized models is one of the major impediments limiting their use in trials, as humanized models used in trials can cost thousands of dollars even for a single patient. Additionally, using humanized models in government-funded basic research is too costly, which may challenge regional market growth.

Humanized Mice Model Market report scope:

Key Takeaways from this Humanized Mice Model Market Report

• Estimate Humanized Mice Model Market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the Humanized Mice Model Market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

What is the CAGR of Humanized Mice Model Market?

The Humanized Mice Model Market is growing at a CAGR of 9.54% During Forecast Period.

 What are the key types of Humanized Mice Model Market?

Humanized Mouse Models, Humanized Rat Models

What are the key applications of Humanized Mice Model Market?

Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions                                                                                                   

Who are the key players in Humanized Mice Model Market?

Ingenious Targeting Laboratory, Axen, rans Genic Inc., Horizon Discovery Group PLC, HuMurine Technologies, Champions Oncology Inc., And others.